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Abstract
Background: Oligoarrays have become an accessible technique for exploring the transcriptome,
but it is presently unclear how absolute transcript data from this technique compare to the data
achieved with tag-based quantitative techniques, such as massively parallel signature sequencing
(MPSS) and serial analysis of gene expression (SAGE). By use of the TransCount method we
calculated absolute transcript concentrations from spotted oligoarray intensities, enabling direct
comparisons with tag counts obtained with MPSS and SAGE. The tag counts were converted to
number of transcripts per cell by assuming that the sum of all transcripts in a single cell was 5·105.
Our aim was to investigate whether the less resource demanding and more widespread oligoarray
technique could provide data that were correlated to and had the same absolute scale as those
obtained with MPSS and SAGE.
Results:  A number of 1,777 unique transcripts were detected in common for the three
technologies and served as the basis for our analyses. The correlations involving the oligoarray data
were not weaker than, but, similar to the correlation between the MPSS and SAGE data, both when
the entire concentration range was considered and at high concentrations. The data sets were
more strongly correlated at high transcript concentrations than at low concentrations. On an
absolute scale, the number of transcripts per cell and gene was generally higher based on
oligoarrays than on MPSS and SAGE, and ranged from 1.6 to 9,705 for the 1,777 overlapping genes.
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The MPSS data were on same scale as the SAGE data, ranging from 0.5 to 3,180 (MPSS) and 9
to1,268 (SAGE) transcripts per cell and gene. The sum of all transcripts per cell for these genes
was 3.8·105 (oligoarrays), 1.1·105 (MPSS) and 7.6·104 (SAGE), whereas the corresponding sum for
all detected transcripts was 1.1·106 (oligoarrays), 2.8·105 (MPSS) and 3.8·105 (SAGE).
Conclusion: The oligoarrays and TransCount provide quantitative transcript concentrations that
are correlated to MPSS and SAGE data, but, the absolute scale of the measurements differs across
the technologies. The discrepancy questions whether the sum of all transcripts within a single cell
might be higher than the number of 5·105 suggested in the literature and used to convert tag counts
to transcripts per cell. If so, this may explain the apparent higher transcript detection efficiency of
the oligoarrays, and has to be clarified before absolute transcript concentrations can be
interchanged across the technologies. The ability to obtain transcript concentrations from
oligoarrays opens up the possibility of efficient generation of universal transcript databases with low
resource demands.
Background
Genomic advances, particularly in sequencing projects,
have fueled the progressive development of high through-
put technologies for measurement of transcript abun-
dance. The most frequently used techniques are the gene
expression microarrays [1], serial analysis of gene expres-
sion (SAGE) [2], and massively parallel signature
sequencing (MPSS) [3]. There are weaknesses and
strengths associated with each of the technologies, and the
choice of method depends on the problem to be solved.
MPSS and SAGE rely on open-based sampling of tran-
scripts, allowing for the identification of novel transcribed
sequences. The complexity of these methods has, how-
ever, limited their utility. The less resource demanding
and more routinely used microarray platform is a hybrid-
ization-based, closed system where the transcript infor-
mation is restricted to pre-selected probes immobilized
on the array [1]. The technologies complement each other
and are useful for different purposes, implying that the
ability to interchange data across them can be of high
value [4]. Hence, large amounts of data that are generated
with these techniques and accumulated in publicly avail-
able repositories could potentially be merged to create
transcript databases of various tissues and used for valida-
tion and meta-study purposes. However, before the repos-
itories can be fully utilized in this way, the consistency in
the measurements on an absolute scale has to be verified.
To our knowledge this has not been done so far, probably
due to the lack of a common measurement unit that ena-
bles direct comparisons across the technologies.
SAGE and MPSS provide absolute transcript abundance
through transcript sampling, sequencing, and identifica-
tion. They both identify and quantify the transcripts
through the generation of short sequence tags (10–22 bp)
from the mRNA molecules and present the data as tag
counts, facilitating comparisons across these techniques.
Tags generated by SAGE are concatemerized and cloned
into vectors for conventional dideoxy-sequencing [2]. In
MPSS the tags are amplified, loaded onto a microbead
library, and immobilized in a flow cell for automated
highly-parallel sequencing [3]. Quantification is obtained
by counting the frequency of each of the tag sequences in
the library, followed by a mapping procedure, which
annotates tag to gene. An advantage of MPSS compared to
SAGE is the larger library size obtainable when using the
same number of sequencing runs [5]. Moreover, the MPSS
tags are generally longer, conferring higher specificity with
respect to tag annotation.
The microarray technique uses the signal intensity of each
array probe as a measure of the mRNA level [1]. There are
three major platforms, spotted cDNA arrays, spotted oli-
goarrays, and in situ-synthesized oligoarrays [6]. The data
from the spotted arrays are generally presented as the
intensity ratio between two samples hybridized together,
whereas for in situ-synthesized oligoarrays the intensities
per se have also been used. A fairly good concordance
between the data achieved from the different platforms
has been demonstrated [7,8]. However, the relative quan-
tification format makes a direct comparison of microarray
data with results from other techniques difficult.
Methods to estimate absolute transcript concentrations
from microarray data that may be useful for comparisons
across technologies have been proposed [9,10]. The
TransCount method developed by Frigessi et al. [10] is
based on Bayesian statistical modeling and utilizes covari-
ates of the microarray experiment to calculate the concen-
tration from the signal intensity of each probe on spotted
arrays. The concentration estimate seems to be a more reli-
able measure of the transcript abundance than the expres-
sion ratio usually derived [10]. We have previously
applied the method to determine the number of tran-
scripts needed prior to mRNA amplification to obtain reli-
able expression data from a limited sample quantity [11].
The use of TransCount and the absolute transcript concen-
trations provides a unique opportunity to explore the con-BMC Genomics 2008, 9:258 http://www.biomedcentral.com/1471-2164/9/258
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sistency in the data achieved with spotted microarrays,
MPSS, and SAGE on an absolute scale.
In a recent study we explored the correlations between
microarray and MPSS data on a relative scale [4]. The limi-
tations inherent to these technologies were discussed as rea-
sons for the reduced consistency across the technologies
compared to within the different hybridization-based tech-
niques. In the present work, we have applied TransCount
and estimated transcript concentrations from oligoarray
intensities of adult mouse retina, in order to investigate
whether the spotted oligoarray technique could provide
data that correlated with and had the same scale as those
obtained with MPSS and SAGE. We performed a direct
comparison between the data sets by converting the tran-
script concentrations and tag counts to the number of tran-
scripts per cell for each individual gene. Our data suggest
that the oligoarrays and TransCount can be used as a sub-
stitute to the tag-based techniques for a quantitative explo-
ration of the transcriptome provided that a discrepancy in
the absolute scale across the technologies is clarified.
Results
Transcript concentrations in adult mouse retina
Oligoarray transcript data were achieved for 14,045 of the
14,076 array probes, showing signal intensities within the
whole detection range. The probes were mapped to 9,786
unique UniGene identification numbers (IDs). Tran-
scripts were detected for all UniGene IDs, with concentra-
tion ranging over five orders of magnitude (Table 1, Figure
1A). The total transcript concentration for the 9,786 genes
was estimated to 1.1·1011 transcripts per μg total RNA,
corresponding to 1.1·106 transcripts per cell and an aver-
age value of 112 (range 0.3 – 14,387) transcripts per cell
and gene (Table 1).
MPSS had 6,572 signatures that were reliably mapped to
UniGene IDs, out of a total of 34,341 unique tags detected
in our library. Among the tags filtered out, 647 were sus-
pected to be in repeated regions, 6,044 had hits on the
genomic sequence, but not within transcripts, 5,415 hit
the reverse strand, and 14,432 hit the transcripts either
without known orientation or without annotated poly(A)
tail or polyadenylation signal. There was also a remaining
small fraction (4.4%) of signatures that produced no
sequence match, most likely attributable to sequencing
errors. The 6,572 reliable signatures were mapped to
6,088 unique UniGene IDs with a tag count ranging over
four orders of magnitude (Table 1, Figure 1B). The sum of
tag counts for all genes was 5.6·105  tpm, leading to
2.8·105 transcripts per cell and on average 46 (range 0.5 –
11,004) transcripts per cell and gene (Table 1).
Our SAGE library contained 12,588 unique tags, which
were mapped to 4,827 unique UniGene IDs with a tag
count ranging over less than three orders of magnitude
(Table 1, Figure 1C). A total of 999 of these were UniGene
clusters and included more than one tag. The sum of tag
counts for 4,827 genes was 7.6·105 tpm, the number of
transcripts per cell was 3.8·105, and the average number
of transcripts per cell and gene was 38 (range 9 – 3,240)
(Table 1).
Table 1: Transcript data of adult mouse retina obtained with high throughput technologies
Oligoarrays MPSS SAGE
All detected genes
No. of unique transcripts1 9,786 6,088 4,827
Total transcript concentration2 1.1·1011 (no. per μg total RNA) 5.6·105 (tpm) 7.6·105 (tpm)
Average transcript concentration (range)3,4 1.1·107 (3.1·104 – 1.4·109) (no. per μg total RNA) 92 (1 – 22,008) (tpm) 77 (18 – 6,480) (tpm)
Total no. transcripts per cell2,3 1.1·106 2.8·105 3.8·105
Average no. of transcripts per cell and gene 
(range)3,4
112 (0.3 – 14,387) 46 (0.5 – 11,004) 38 (9 – 3,240)
Overlapping genes
No. of unique transcripts1 1,777 1,777 1,777
Total transcript concentration2 3.8·1010 (no. per μg total RNA) 2.2·105 (tpm) 1.5·105 (tpm)
Average transcript concentration (range)3,4 2.1·107 (1.6·105 – 9.7·108) (no. per μg total RNA) 126 (1 – 6,360) (tpm) 86 (18 – 2,536) (tpm)
Total no. transcripts per cell2,3 3.8·105 1.1·105 7.6·104
Average no. of transcripts per cell and gene 
(range)3,4
213 (1.6 – 9,705) 63 (0.5 – 3,180) 43 (9 – 1,268)
1 Mapped to UniGene identifiers.
2 Sum for all genes.
3 10 pg total RNA per cell was assumed for oligoarrays, and a total number of 5·105 transcripts per cell was applied for SAGE and MPSS in the 
calculation.
4 Average and range for all genes.BMC Genomics 2008, 9:258 http://www.biomedcentral.com/1471-2164/9/258
Page 4 of 11
(page number not for citation purposes)
Cross-platform correlations
The three data sets were matched pair-wise according to
the UniGene IDs. The number of genes in common for
oligoarrays and MPSS was 3,192, while 2,536 and 3,328
genes overlapped between oligoarrays and SAGE, and
between MPSS and SAGE, respectively (Figure 2). A subset
of 1,777 genes was identified in all three data sets, show-
ing transcript concentrations in the range of 1.6·105 –
9.7·108 transcripts per μg total RNA (oligoarrays), 1 –
6,360 tpm (MPSS), and 18 – 2,536 tpm (SAGE) (Table 1,
Additional file 1). Comparison of the oligoarray and
MPSS data, oligoarray and SAGE data, and MPSS and
SAGE data of the 1,777 overlapping genes showed similar
relationship with correlation coefficients within the range
of 0.54 – 0.60 (Figure 3). The corresponding coefficients
based on log transformed data were somewhat lower and
ranged from 0.46 – 0.48, showing that the highest tran-
script concentrations contributed considerably to the cor-
relations of the untransformed data.
To further explore the consistency in the data at different
transcript concentrations, for each technology we consid-
ered two subsets of 100 genes each, one with the highest
and another with the lowest concentrations, selected from
the data sets of the 1,777 overlapping genes. The expres-
sion level of the poorly and highly expressed genes was
confirmed by qRT-PCR analysis (Table 2). At the highest
transcript concentration, 35 of 100 genes were in com-
mon to all technologies, whereas only 5 genes overlapped
at the lowest concentration (Figure 4). Similar patterns of
intersection were found when more genes were consid-
ered (data not shown), showing increased consistency at
Venn diagram showing the number and overlap in unique  transcripts detected in adult mouse retina by oligoarrays,  MPSS, and SAGE Figure 2
Venn diagram showing the number and overlap in 
unique transcripts detected in adult mouse retina by 
oligoarrays, MPSS, and SAGE. N is total number of 
unique transcripts detected with the respective technologies.
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Frequency distributions of the transcript concentrations  measured in adult mouse retina by oligoarrays (A), MPSS (B),  and SAGE (C) Figure 1
Frequency distributions of the transcript concentra-
tions measured in adult mouse retina by oligoarrays 
(A), MPSS (B), and SAGE (C). The histograms are based 
on the 9,786 (A), 6,088 (B) and 4,827 (C) unique transcripts 
detected with each technology.
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high concentrations. Although the concentration range of
the 35 most abundant transcripts held in common was
narrow, their oligoarray data were significantly correlated
to the MPSS and SAGE data (Figure 3). The MPSS and
SAGE data were not significantly correlated.
Absolute scale comparisons
Transforming the data to numbers of transcripts per cell
and gene allowed us to compare the absolute scale of the
measurements for each individual gene across the tech-
nologies, applying the three data sets of the 1,777 overlap-
ping genes. The oligoarray values ranged from 1.6 to
9,705 transcripts per cell and gene and were significantly
higher than the MPSS and SAGE values (p < 0.001, Fried-
man test in ANOVA on ranks), which ranged from 0.5 to
3,180 (MPSS) and from 9 to 1,268 (SAGE) transcripts per
cell and gene (Table 1, Additional file 1). Hence, Ubb,
showing the maximum number of transcripts per cell
based on oligoarrays (9,705) had only 401 and 435 tran-
scripts per cell based on MPSS and SAGE, respectively
(Table 2). More consistent results were, however, achieved
for other genes, like Plekhb1 (931, 474, 620 transcripts per
cell) and Laptm4b  (634, 451, 352 transcripts per cell)
(Table 2). The average number of transcripts per cell was
213 (oligoarrays), 63 (MPSS), and 43 (SAGE).
The absolute transcript concentrations also enabled us to
compare the detection efficiency at different transcript
concentrations among the technologies. For the 35 most
abundant transcripts held in common, a total number of
89891, 25687, and 13655 transcripts per cell were
detected with the oligoarray, MPSS, and SAGE technique,
respectively (Table 2). Assuming that all these were true
transcripts, MPSS detected 29% and SAGE 15% of those
detected with oligoarrays. For the 5 overlapping genes at
low transcript concentration, MPSS detected 8 (10%) and
SAGE 45 (56%) of the totally 80 transcripts detected with
oligoarrays (Table 2). The median detection efficiency
based on all overlapping genes was 21% (MPSS) and 23%
(SAGE), as compared to the oligoarray data. The oligoar-
rays therefore seemed to be more sensitive in detecting
known transcripts.
Discussion
The use of TransCount to retrieve absolute units from oli-
goarray data in our study enabled a quantitative compari-
son of transcript concentrations across MPSS, SAGE, and
spotted oligoarrays. Although several studies have com-
pared the performance of tag-based and hybridization-
based gene expression platforms [4,12-19], our focus on a
common measurement unit has to our knowledge not
received detailed attention so far. Previous comparisons
involving microarrays have utilized the signal intensities
[4,12-19]. The intensities of in situ-synthesized oligoarrays
may possibly reflect the transcript concentration reasona-
Comparison of transcript concentrations measured in adult  mouse retina with oligoarrays and MPSS (A), oligoarrays and  SAGE (B), and MPSS and SAGE (C) Figure 3
Comparison of transcript concentrations measured 
in adult mouse retina with oligoarrays and MPSS (A), 
oligoarrays and SAGE (B), and MPSS and SAGE (C). 
Data for 1,777 overlapping genes are shown on a logarithmic 
scale. Each dot represents the data of a single gene. The 
Pearson product moment correlation coefficients, r, are indi-
cated (p < 0.0001 for all). The corresponding coefficients 
based on the log transformed data were 0.46 (A), 0.48 (B), 
and 0.48 (C) (p < 0.0001 for all). The 40 transcripts in com-
mon for all three technologies among two subsets of 100 
genes each, one with the highest and another with the lowest 
transcript concentrations, are indicated by red dots. The 
correlation coefficient of the 35 transcripts with the highest 
concentrations were 0.49, p = 0.003 (A), 0.41, p = 0.01 (B), 
0.22, p = 0.2 (C). Analysis of log transformed data showed 
correlation coefficients of 0.51, p = 0.002 (A), 0.45, p = 0.007 
(B), and 0.30, p = 0.08. Number of transcripts per cell for 
these genes is listed in Table 2.
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bly well, but intensities are not suitable when spotted
arrays are used and not directly comparable across experi-
ments and platforms. By our approach, the numbers of
transcripts per cell were calculated genome-wide for all
three technologies. These values could be compared
directly across the technologies, and a thorough valida-
tion of oligoarrays for quantitative exploration of the tran-
scriptome could be performed.
Our study did not allow for a general evaluation of the
transcriptome coverage of each platform, since differences
in the sampling depth among the technologies would bias
the outcome. Given our sampling depths of 1.6 million
and 55,000, which are commonly used in MPSS and
SAGE experiments respectively, only about 60% (MPSS)
and 10% (SAGE) of the transcripts with 1–5 copies per
cell are expected to be detected [20]. Hence, to identify
Table 2: Transcript concentration of selected genes in adult mouse retina1 
UniGene ID Gene Symbol Gene name Oligoarray MPSS SAGE qRT-PCR
Genes with high expression
Mm.371592 Ubb Ubiquitin B 9705 401 435 NA
Mm.368524 8916 3180 722 NA
Mm.47709 Pdc Phosducin 6027 516 425 10.36
Mm.151562 Rbp3 Retinol binding protein 3 5733 1292 657 4.77
Mm.16224 Guca1a Guanylate cyclase activator 1a (retina) 5366 611 546 0.66
Mm.284811 Unc119 Unc-119 homolog (C.elegans) 4812 335 1046 2.40
Mm.59151 Guca1b Guanylate cyclase activator 1B 4478 3116 287 1.44
Mm.235863 4046 1312 361 NA
Mm.285993 Calm1 Calmodulin 1 3304 543 222 3.09
Mm.28643 Vamp2 Vesicle-associated membrane protein2 3250 683 296 2.63
Mm.16831 Ckb Creatine kinase, brain 2896 1164 620 NA
Mm.223674 Syp Synaptophysin 2592 595 130 0.16
Mm.1372 Pde6b Diesterase 6B, cGMP, rod reseptor, beta polypeptide 2400 956 982 1.73
Mm.156506 Pcdh21 Protocadherin 21 2137 570 232 1.80
Mm.297482 Tpt1 Tumor protein, translationally controlled 1 1742 359 750 1.44
Mm.3667 Vtn Vitronectin 1630 634 398 1.74
Mm.352239 Gpsn2 Glycoprotein, synaptic 2 1579 484 287 0.02
Mm.55143 Dkk3 Dickkopf homolog 3 (Xenopus laevis) 1576 266 185 0.10
Mm.726 Bsg Basigin 1490 870 268 0.87
Mm.683 1472 236 407 NA
Mm.28147 Reep6 Receptor accessory protein 6 1394 1229 445 3.42
Mm.273538 cDNA, clone Y1G0119M19 1389 375 259 NA
Mm.16228 Slc25a4 Solute carrier family 25, member 4 1382 520 416 0.67
Mm.235204 Atp1b2 ATPase, Na+/K+ transporting, beta 2 polypeptide 1210 466 213 1.79
Mm.94160 Bex2 Brain expressed X-linked 2 1171 339 139 0.09
Mm.331 Ubc Ubiquitin C 1165 423 130 NA
Mm.26633 Plekhb1 Pleckstrin homology domain containing, family B member 1 931 474 620 0.32
Mm.305152 Apoe Apolipoprotein E 920 1046 213 0.25
Mm.200608 Clu Clusterin 885 456 222 0.07
Mm.278865 Stxbp1 Syntaxin binding protein 1 873 512 389 0.60
Mm.236513 Pcbp2 Poly(rC) binding protein 2 777 401 325 1.78
Mm.41926 698 271 130 NA
Mm.373613 661 340 268 NA
Mm.379381 650 261 278 NA
Mm.197518 Laptm4b Lysosomal-associated protein transmembrane 4B 634 451 352 0.30
Genes with low expression
Mm.24678 Pard6g Par-6 partitioning defective 6 homolog gamma (C. elegans) 13 2 9 0.01
Mm.273155 2610110G12Rik RIKEN cDNA 2610110G12 gene 14 2 9 0.00
Mm.1249 Lamc1 Laminin, gamma 1 14 1 9 NA
Mm.261831 19 1 9 NA
Mm.257952 Tmem159 Transmembrane protein 159 20 2 9 0.01
1The 40 transcripts in common for oligoarrays, MPSS and SAGE among two subsets of 100 genes each, one with the highest and another with the 
lowest transcript concentrations. The values are listed as number of transcripts per cell for oligoarrays, MPSS and SAGE, and as relative to the 
endogenous control β-actin (Actb) for qRT-PCR. NA means not analysed.BMC Genomics 2008, 9:258 http://www.biomedcentral.com/1471-2164/9/258
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90% of the expressed genes, sequencing of about three
million tags is probably required [20], leading to a signif-
icant increase in the costs of these experiments. In con-
trast, transcriptome coverage in the oligoarray data was
more explicitly defined and easier to be ensured by per-
forming four replicate experiments. Rapid advances in the
development of next generation sequencing technologies
may eventually fill this gap by allowing for significant
improvements in the sampling depth at dramatically
reduced cost and time. On the other hand, the aim of this
study was to validate the quantitative potential of the oli-
goarrays. We therefore focused primarily on the subset of
genes detected by all three technologies, through a strin-
gent mapping of MPSS and SAGE tags to known genes,
with a further limit to those also present in the oligoarray
design. This explains why the number of unique tran-
scripts detected was lower for the tag-based techniques
than for the oligoarrays. Although the increase in sam-
pling depth of tag-based technologies may considerably
facilitate better transcriptome coverage, it is not a crucial
concern in our study.
The oligoarray estimates showed a stronger relationship
to the MPSS and SAGE data than that previously reported
for spotted oligoarrays [13], possibly because we used
absolute transcript concentrations and not intensities in
the analysis. Hence, we have previously shown that the
absolute transcript concentrations derived from Trans-
Count is more strongly correlated to qRT-PCR data than
are the relative values achieved from traditional microar-
ray analysis, suggesting that they are more reliable meas-
ures of the transcript abundance [10]. Otherwise, our
results, including the particularly poor correlation at low
concentrations, were in agreement with earlier reports
[12-19]. A correlation coefficient of about 0.50–0.60
therefore probably reflects the overall consistency across
the technologies when genes at all expression levels are
included. The correlations involving the oligoarray data
were not weaker than, but, similar to the correlation
between the MPSS and SAGE data, both when the entire
concentration range was considered and at high concen-
trations. Inherent technological differences in the detec-
tion and quantification processes between the techniques
probably caused some inconsistency between the data
sets. Disadvantages related to the respective technologies,
such as cross-hybridization, sampling variances, and tag
annotation ambiguities may have contributed [18,19,21].
The discrepancy was therefore probably caused by errone-
ous measurements in all data sets.
The correlations involving the SAGE data may have been
influenced by the use of another RNA pool in these exper-
iments than in the MPSS and oligoarray experiments.
Mouse retina generally shows low variability in gene
expression, minimizing possible confounding effects
caused by differences in the RNA pools. Hence, in a recent
study we showed that data variation introduced by bio-
logical replicates of the mouse retina is small compared to
the variation caused by using different technologies [4].
Moreover, the correlation to oligoarray data was some-
what stronger for the SAGE than the MPSS data. The use
Venn diagram showing the number and overlap in unique  transcripts detected in adult mouse retina by oligoarrays,  MPSS, and SAGE Figure 4
Venn diagram showing the number and overlap in 
unique transcripts detected in adult mouse retina by 
oligoarrays, MPSS, and SAGE. In (A) the 100 most abun-
dant transcripts for each technology were considered, 
whereas in (B) the 100 transcripts with the lowest concen-
tration were selected. Number of transcripts per cell for 
those held in common for all technologies is listed in Table 2.
35 
12
Oligoarrays
N = 100
MPSS
N = 100
SAGE
N = 100
16 
37 
15 
38 
34 
5 
5 
Oligoarrays
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of another RNA pool for the SAGE experiments had there-
fore probably minor influence on our results.
The number of transcripts per cell was considerably higher
based on oligoarrays and TransCount than based on
MPSS and SAGE, both at high and low concentrations.
The difference in the absolute scale of the measurements
depends on the values used for the sum of all transcripts
and the total RNA content per cell in the MPSS/SAGE and
oligoarray calculations, respectively. Our oligoarray
results suggest that the maximum number of transcripts
may exceed one million, which is more than two-fold
higher than the 5·105 reported in a study from 1976 [22]
that was used in our MPSS and SAGE estimations. Adjust-
ing this number to 1.5·106 transcript per cell would have
led to MPSS and SAGE values more comparable to the
absolute oligoarray data. Consequently, the calculated
transcript detection efficiency will also be more similar for
the three technologies. Hence, the transcript detection
efficiency seemed to be considerable higher for the oli-
goarrays when the value of 5·105 transcript per cell was
used in the MPSS and SAGE estimations. More recent
studies exploring the number of transcripts in cells have
not been performed, except for a microarray study where
spike-in controls were used to define a standard curve,
which related signal intensity to the absolute transcript
numbers [9]. The transcript values were two- to three-fold
lower than ours, but the apparent discrepancy was solely
due to the use of a highly conservative value of 2–3 pg
total RNA per cell in their calculations. Our estimate of 10
pg per cell is within the range of previously reported data
[23,24], and probably closer to the true value. The find-
ings reported in the other microarray study [9] are there-
fore in agreement with our results. Although the error
range of the oligoarray estimates is relatively large [10]
and the data may be somewhat overestimated, due to pos-
sible unspecific binding to array probes [25] and experi-
mental uncertainty in the scaling of the absolute values
[10], these findings strongly suggest that the value of
5·105  should be re-examined and probably elevated.
MPSS and SAGE would then be found to have a weaker
coverage than previously anticipated.
The increased estimate for the sum of all transcripts per
cell based on oligoarrays was also reflected in a higher
number of transcripts per cell and gene, as compared to
the MPSS and SAGE results. A number of about 10,000
transcripts was estimated for several genes, and numbers
above 5,000 were found for 15 genes, when considering
all the detected transcripts. In contrast, only three genes
had a transcript number above 5,000 by MPSS, whereas
by SAGE the highest number was 3,240. More than
10,000 transcripts per cell have been reported for individ-
ual genes and gene groups in several studies on mouse tis-
sues [20,26-28], consistent with our oligoarray data.
Moreover, TransCount estimations for cervical cancers
based on cDNA microarrays led to values in agreement
with the present oligoarray results [10]. These observa-
tions further question the validity of the total transcript
number of 5·105 per cell that was used in the MPSS and
SAGE calculations. In that respect, a recent SAGE study
showed that using a total number of 1·106 transcripts per
cell to convert the tag counts led to absolute transcript
numbers consistent with the published values mentioned
above [20], supporting our findings.
A thorough evaluation of genes expressed in adult mouse
retina and their putative function have been presented in
previous studies based on the SAGE data [29,30]. Here, we
focused on 40 genes with particularly high or low expres-
sion regardless of technology, suggesting that these are
truly up- or downregulated compared to the average
expression level. The most abundant transcripts are
known to be involved in visual perception (Pdc, Rbp3,
Guca1a, Unc119, Guca1b, Pde6b) or play another role in
retinal function (Calm1, Syp) [30]. Moreover, high expres-
sion of Bsg, Plekhb1, Reep6, and Stxbp1 has been reported
in the retina, photoreceptors, and/or eye [31-33]. Our
findings are therefore consistent with previous reports
and point to more genes that may be explored to increase
our understanding of retinal function, like Ubb  and
Vamp2. The data also support the hypothesis that the most
abundant transcripts are tissue specific and involved in
specialized functions, whereas the larger number of less
abundant transcripts may be involved in housekeeping
activities and shared between tissues, as suggested from
studies on the mouse liver [22].
Conclusion
The transcript concentrations estimated from spotted oli-
goarrays by use of TransCount are correlated to those
obtained with MPSS and SAGE. Oligoarrays and Trans-
Count may therefore play a role in an efficiently building
of transcript repositories at low costs and labor demands.
Such quantitative data may also enable insight into new
aspects of the transcriptome and a better understanding of
gene networks [34]. Clarification of the discrepancy in the
absolute scale of the measurements would imply that data
may be interchanged across hybridization- and tag-based
technologies.
Methods
Tissue sample
Total RNA from B6 adult mouse retina was used through-
out the study. The oligoarray and MPSS experiments were
based on the same RNA pool, whereas a different pool
was used in the SAGE experiments [29]. Details of the
sample collection and RNA extraction can be found in
Kuo et al. [7]. Quality assessment was performed on a Bio-BMC Genomics 2008, 9:258 http://www.biomedcentral.com/1471-2164/9/258
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analyzer (Agilent Technologies, Inc., Santa Clara, CA) to
ensure that high quality RNA was used.
Microarray experiments
Spotted mouse 70-mer oligoarrays produced at the micro-
array facility at the Norwegian University of Science and
Technology were used. The arrays contained 32,448 spots
with 14,076 unique probes printed from an oligonucle-
otide set originating from the Operon mouse oligo collec-
tion v3.0 (Operon Biotechnologies, Inc, Huntsville, AL).
Control probes from the Spot Report Alien Oligo Array
Validation System (Stratagene, La Jolla, CA) were printed
48 times each across the array. The control spots were used
by TransCount to find the absolute scale of the transcript
concentrations [10]. A self-self hybridization design with
4 array replicates was used.
Cy3 and Cy5 labeled cDNA was synthesized from 13.5 –
15 μg total RNA, as described previously [10]. The quality
of the labeled cDNA was assessed from the ratio of
absorbance at 260 nm and 280 nm, as measured by use of
a NanoDrop spectrophotometer (NanoDrop Technolo-
gies, Wilmington, DE). The quality was found to be satis-
factory. To target the control probes, 9 control mRNA
spikes from the Spot Report system were added to the
reaction mixtures at well-defined concentrations, ranging
from 3.3 × 107 to 2.7 × 109 mRNA molecules. A 25% for-
mamide-based hybridization buffer was added to the
labeled target mixture, and the mixture was applied to the
array for overnight hybridization at 42°C in a water bath.
The slides were scanned by an Agilent G2566AA scanner
(Agilent Technologies, Inc., Santa Clara, CA) at two PMT
settings of 100 and 50, enabling correction of saturated
spot intensities [35] and estimation of the scanner ampli-
fication factors needed in TransCount to calculate the
transcript concentrations [10].
The TransCount method, originally developed for cDNA
microarrays [10], was applied with small modifications
for oligoarrays. The sequence length of all probes was 70
bp, and the intensities from a slide stained with SYTO
nucleic acid staining dye (Molecular Probes, Inc, Eugene,
OR) were used as probe quantities. Since oligoarrays are
affected by less experimental variation than cDNA micro-
arrays, TransCount could be directly applied with these
modifications [10]. The transcript concentrations were
estimated from the saturation and background corrected
intensities of each probe and oligoarray. The intensities of
the control spots covered the whole detection range from
near background values to saturation. The estimated con-
centrations of these spots showed a highly linear relation-
ship to the true concentrations, suggesting reliable scaling
of the concentrations of the other spots. The mean con-
centrations of the four data sets were used in the further
analyses. The average number of transcripts per cell was
calculated by assuming a total RNA content of 10 pg per
cell [23]. Each probe was assigned a UniGene ID by
searching the best sequence match in the mouse UniGene
build 151 to the probe sequence. If more than one probe
was mapped to the same UniGene ID, their transcript esti-
mates were averaged.
MPSS
Total RNA samples were sent to Lynx Therapeutics (now
Illumina, Hayward, CA) for processing. The MPSS library
was generated according to the Megaclone protocol [3].
Signatures adjacent to poly(A) proximal DpnII restriction
sites, comprising of 20 nucleotides each, including the
DpnII recognition sequence "GATC", were cloned into a
Megaclone vector. The resulting library was amplified and
loaded onto microbeads. About 1.6 million microbeads
were loaded into a flow cell, and the signature sequences
of 17 bases were read out by a series of enzymatic reac-
tions. The abundance of each signature was converted to
transcripts per million (tpm).
The mapping of signatures to genes was based on the
mouse genome sequence (UCSC GoldenPath genome
database, Release 3, Feb 2003) and the UniGene build
151, using the Automatic Correspondence of Tags and
Genes (ACTG) tool [36]. A complete set of possible "vir-
tual signatures" was extracted from the sequence database
to generate a comprehensive mouse signature collection,
and all signatures were ranked and classified according to
the likelihood of being a true and detectable signature. If
a signature had been located close to a polyadenylation
signal or a poly(A) tail on mRNA sequences with known
orientation, the credibility of the tag-to-gene assignment
was the highest, and the signature was included. In con-
trast, if a signature was extracted from mRNA sequences
whose transcriptional orientation, polyadenylation fea-
tures, or position information was unknown, or had been
found only in non-coding regions or repeated structures,
it was filtered out. Such hits may have been generated due
to the currently incomplete annotation of the murine
genome, or due to sequencing errors in the MPSS experi-
ments. For genes with more than one representative tag
sequence, all the corresponding tag counts were summed
up. To calculate the average number of transcripts per cell
the number of tags per million was divided by two,
assuming that the total number of transcripts per cell was
5·105 [22].
SAGE
The SAGE data from a previously published study were
used [29]. Generation of the SAGE transcript library and
the data processing to extract tags and eliminate dupli-
cates have been described earlier [29]. The total number ofBMC Genomics 2008, 9:258 http://www.biomedcentral.com/1471-2164/9/258
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sequenced tags in the library was about 55,000. The tag
counts, originally normalized to 55,000, were converted
to tags per million (tpm). The tag-to-gene mapping was
performed using the ACTG tool based on a SAGEmap data
release with UniGene build 151 [37]. Only the tags that
had a reliable tag-to-UniGene match in SAGEmap were
included for further analyses. For cases where more than
one tag was mapped to one gene, the tag counts were
pooled in the same manner as for the MPSS data. The
average number of transcripts per cell was calculated as for
the MPSS data.
Quantitative real-time PCR
We used qRT-PCR to confirm the mRNA levels of 28 genes
listed in Table 2. Our criteria for designing the primers
included that they were intron-spanning. This was not the
case for 7 of the 35 genes in Table 2, and these were there-
fore not analysed. QRT-PCR was applied, using Roche 480
LightCycler. Mouse Universal ProbeLibrary probes and
target-specific PCR primers (Additional file 2) were
selected using the ProbeFinder assay design software [38].
All assays were prepared using standard conditions in a
master mix solution (Roche Applied Sciences). cDNA was
synthesized from 10 μg of total RNA for each sample
using Roche reverse-transcriptase. The reactions were run
in triplicate for each gene, using 20 μl reaction volumes
and the following conditions: 95°C for 5 minutes, 45
cycles for 95°C for 10 seconds, 60°C for 15 seconds, and
72°C for one second. Dilution curves were made to
ensure appreciable amplification efficiency (Additional
file 3). The transcript concentrations were calculated rela-
tive to the endogenous control β-actin (Actb) as
, where CtGene and CtActb correspond to the
mean cycle thresholds for the test gene and β-actin,
respectively [39].
Array express accession
The raw data from the oligoarray platform have been
deposited to the Array Express repository (E-TABM-422).
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